Are you Dr. Lampson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-732-6089Fax+1 617-732-5706
Summary
- Dr. Benjamin Lampson, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and Brigham and Women's Hospital.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2012 - 2015
Duke University School of MedicineClass of 2012
Certifications & Licensure
MA State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 52 citationsAcalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 studyMatthew S. Davids, Benjamin L. Lampson, Svitlana Tyekucheva, Zixu Wang, Jessica Lowney
The Lancet. Oncology. 2021-10-01 - 144 citationsVentricular arrhythmias and sudden death in patients taking ibrutinibBenjamin L. Lampson, Lijian Yu, Robert J. Glynn, Jacqueline C. Barrientos, Eric D. Jacobsen
Blood. 2016-09-01 - 50 citationsAre BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemiaBenjamin L. Lampson, Jennifer R. Brown
Expert Review of Hematology. 2018-02-12
Press Mentions
Frontline Triplet Regimen Induces Undetectable MRD in the Bone Marrow of Patients with CLLDecember 9th, 2019
